Zdrowie i gospodarka · 27/08/2014

FDA Releases Guidance for Highly Multiplexed Microbiological/Medical Countermeasure Diagnostic Devices

The FDA has made available a guidance document outlining recommendations for evaluating the performance of highly multiplexed microbiological/medical countermeasure in vitro nucleic acid-based diagnostic devices, which can detect multiple pathogens from a single human specimen or culture.